Across 32 tumor types, SAS was moderately negatively correlated with IFN-γ response (R = − 0.25, p < 2.2e−16) and more strongly with TGF-β response (R = − 0.30, p < 2.2e−16) (Fig. 1D). The gene discussed is TGFB1; the disease is neoplasm.